UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010709 |
|---|---|
| Receipt number | R000012169 |
| Scientific Title | Phase II trial of gefitinib plus pemetrexed after the relapse to gefitinib in the patients with non-small-cell lung cancer harboring EGFR gene mutations. |
| Date of disclosure of the study information | 2013/05/13 |
| Last modified on | 2021/12/10 10:27:44 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/05/13 22:49:14 | ||
| 2 | Update | 2013/12/24 13:08:28 | Organization Email1 |
|
| 3 | Update | 2013/12/24 13:10:14 | Recruitment status |
|
| 4 | Update | 2014/06/20 15:47:53 | Organization Organization Division name Address Address TEL Organization2 Address2 Tel2 Email2 |
|
| 5 | Update | 2016/06/21 17:49:44 | Name of primary person or sponsor Organization Email1 |
|
| 6 | Update | 2021/12/02 16:44:23 | UMIN ID1 |
|
| 7 | Update | 2021/12/10 10:27:44 | Recruitment status Date of IRB Last follow-up date |
